The demand for radiotherapy across all European countries will increase by an average of 16% between 2012 and 2025, with the highest expected increase being for prostate cancer cases (24%), according to a new study published in Radiotherapy and Oncology [1].
These projections come from a new study by HERO, the Health Economics in Radiation Oncology project of the European Society for Radiotherapy and Oncology. The results will also be presented at the ESTRO 35 conference [2], to be held in Turin, Italy, from Friday 29 April - Tuesday 3 May 2016.